Pancreas

University of Iowa Study Reveals High-Dose Vitamin C Doubles Survival Rates for Late-Stage Pancreatic Cancer Patients

A groundbreaking study from the University of Iowa reveals that high-dose intravenous vitamin C therapy could double survival times for late-stage pancreatic cancer patients, increasing their average survival from eight to 16 months. This promising research highlights the potential of vitamin C as a versatile treatment option in oncology, with implications for other cancer types as well.

Rising Pancreatic Cancer Cases Among Youth: A Closer Look at Overdiagnosis

Recent studies indicate a rising incidence of pancreatic cancer among younger individuals in the U.S., yet a new report reveals that most cases are diagnosed early, leading to better outcomes. This challenges the perception of a health crisis, suggesting the need for careful management and screening strategies to balance early detection with the risk of overtreatment.

Chinese Scientists Make Groundbreaking Discovery in Pancreatic Cancer Treatment

Chinese scientists have discovered two protein markers that may predict chemotherapy sensitivity in pancreatic cancer, offering hope for improved survival rates. The groundbreaking study, published in Nature Medicine, could revolutionize the diagnosis and treatment of the most common subtype of pancreatic cancer, offering new hope for patients and the medical community.

Strategies for a Healthy Pancreas

It is crucial to seek medical attention if experiencing symptoms of pancreatitis as early diagnosis and treatment can help prevent further complications. However, there are a few strategies that one must follow for a healthy pancreas. Pancreatitis is a serious…

Diabetes Drug Shows Promise in Protecting Against Colorectal Cancer

A recent analysis by researchers in the US suggests that a drug commonly used to treat type 2 diabetes could also be effective in protecting against colorectal cancer (CRC). The drug, known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs), has…